BRIEF published on 09/30/2024 at 07:35, 1 month 21 days ago TheraVet Announces Strategic Shift to Idiopathic Pulmonary Fibrosis Restructuring Phase II TheraVet H4Orphan Pulmonary Fibrosis
PRESS RELEASE published on 09/30/2024 at 07:30, 1 month 21 days ago Inside Information / Operations of the issuer (acquisitions, sales...) TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024 Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
PRESS RELEASE published on 09/12/2024 at 07:30, 2 months 9 days ago Inside Information / Other news releases TheraVet announces 2024 half-year results with positive sales growth and reduced operating loss. Company focuses on refinancing options and operational milestones Sales Growth Refinancing Operating Loss 2024 Half-year Results TheraVet
Published on 11/21/2024 at 10:03, 47 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 50 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 50 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 15 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 25 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 20 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 45 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 47 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 50 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 50 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 52 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 30 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
